Treatment method using recombinantly produced human membrane cof

Details Treatment method using recombinantly produced human membrane cof Treatment method using recombinantly produced human membrane cof

1995-06-07

1997-12-30

Walsh, Stephen

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530380, 530350, 435 691, 435348, 435349, 4352523, 43525411, A61K 3817, C07K 1447, C07K 14705, C12P 2100

Patent

active

057030464

ABSTRACT:
Human membrane cofactor protein, a protein involved in regulation of complement activity, has been purified to homogeneity. The gene encoding this protein has been retrieved and permits deduction of the entire amino acid sequence and the recombinant production of this material. Pharmaceutical compositions in which MCP is the active ingredient for use in treating antoimmune diseases are also disclosed.

REFERENCES:
patent: 5552381 (1996-09-01), Atkinson
Seya, et al. (1986) J. Exp. Med., 163: 837-855.
Johnson (1977) J. Pharm Sci. 66(10) 1367-1377.
Norbiato, et al. (1986) J. Clin. Endocrinol. Metab., 63 (3): 747-750 (Abstract furnished).
Reid, et al., Immunol. Today (1986) 7:230-234.
Yu, et al., J. Clin. Invest. (1986) 78:494-501.
Medof, et al., Proc. Natl. Acad. Sci . (1987) 84:2007-2011.
Caras, et al., Science (1987) 238:1280-1283.
Ballard, et al., J. Immunol. (1987) 138:3850-3855.
Seya, et al., Eur. J. Immunol. (1988) 18:1289-1294.
Seya, et al., Complement (1987) 4:225.
Hourcade, et al., Adv. Immunol . (1989) 45:381-416.
Lublin, et al., Ann. Rev. Immunol. (1989) 7:35-58.
Lublin, et al., J. Exp. Med. (1987) 165: 1731-1736.
Cole, et al., Proc. Natl. Acad. Sci., (1985) 82:859-863.
Lublin, et al., J. Exp. Med. (1988) 168:181-194.
Ballard, et al., J. Immunol. (1988) 141(11):3923-3929.
McNearney, et al., J. Clin. Invest. (1989) 84:001-008.
Stafford et al., Proc. Natl. Acad. Sci. (1988) 85:880-884.
Bora et al., J. Exp. Med. (1989) 169:597-602.
Farries et al., Complement and Inflamm. (1990) 7:30-41.
Lublin et al., Current Topics in Micro. and Immunology (1989) 153: 123-145.
Hourcade et al., Progress in Immunology (1989) vol. VII:171-177.
Seya et al., (1989) Biochem. J. 164, 7 pages of text.
Holers, et al., Immunol. Today (1985) 6:188-192.
Ross, et al., Adv. Immunol. (1985) 37:217-267.
Atkinson, et al., Immunol. Today . (1987) 8:212-215.
Purcell et al., Immunology (1990) 70: 155-161.
Kim, J. Biol. Chem. (1989) 264(17):9780-9784.
Wong et al., J. Immunol. (1985) 134(6):4048-4056.
Goujet-Zalc et al., Cell. Immunol. (1987) 109:282-294.
Cui et al., FASAB J. (1989) 3:A500, No. 1594.
Seya et al., Biochem. J. (1989) 264:(7 pages of text total).

Affiliated with

Also associated with

Rating

Treatment method using recombinantly produced human membrane cof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment method using recombinantly produced human membrane cof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment method using recombinantly produced human membrane cof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-202257